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Abstract
Background: Overactive bladder is a heterogenous condition with poorly characterized clinical phenotypes. To
discover potential patient subtypes in patients with overactive bladder (OAB), we used consensus clustering of their
urinary symptoms and other non-urologic factors.
Methods: Clinical variables included in the k-means consensus clustering included OAB symptoms, urinary incontinence, anxiety, depression, psychological stress, somatic symptom burden, reported childhood traumatic exposure,
and bladder pain.
Results: 48 OAB patients seeking care of their symptoms were included. k-means consensus clustering identified
two clusters of OAB patients: a urinary cluster and a systemic cluster. The systemic cluster, which consisted of about
half of the cohort (48%), was characterized by significantly higher psychosocial burden of anxiety (HADS-A, 9.5 vs. 3.7,
p < 0.001), depression (HADS-D, 6.9 vs. 3.6, p < 0.001), psychological stress (PSS, 21.4 vs. 12.9, p < 0.001), somatic symptom burden (PSPS-Q, 28.0 vs. 7.5, p < 0.001), and reported exposure to traumatic stress as a child (CTES, 17.0 vs. 5.4,
p < 0.001), compared to the urinary cluster. The systemic cluster also reported more intense bladder pain (3.3 vs. 0.8,
p = 0.002), more widespread distribution of pain (34.8% vs. 4.0%, p = 0.009). The systemic cluster had worse urinary
incontinence (ICIQ-UI, 14.0 vs. 10.7, p = 0.028) and quality of life (SF-36, 43.7 vs. 74.6, p < 0.001). The two clusters were
indistinguishable by their urgency symptoms (ICIQ-OAB, OAB-q, IUSS, 0–10 ratings). The two OAB clusters were different from patients with IC/BPS (worse urgency incontinence and less pain).
Conclusions: The OAB population is heterogeneous and symptom-based clustering has identified two clusters of
OAB patients (a systemic cluster vs. a bladder cluster). Understanding the pathophysiology of OAB subtypes may
facilitate treatments.
Keywords: Overactive bladder, Clustering, Phenotyping
Background
Overactive bladder (OAB) affects 1 in 6 adults in the
United States and has an economic cost of $24.9 billion
[1, 2]. Despite the enormous burden and negative impact
on quality of life, our understanding of the underlying
pathophysiology is poor. Treatment outcomes remain
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suboptimal overall. Most patients do not continue their
medications one year after the prescription [3], and many
patients are “refractory” to OAB treatments.
Recent research suggested that non-urologic factors
such as anxiety, depression, psychological stress, somatic
symptom burden, non-urologic pain, and increased
hypersensitivity related to central sensitization might
contribute to the symptomatology of OAB and other
lower urinary tract symptoms (LUTS) [4–10]. This observation raises the possibility that the OAB population is
heterogeneous and may be further sub-categorized based
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on their non-urologic factors in addition to their urinary
symptoms.
Consensus clustering provides a means to discover
patient subtypes in patient population with heterogeneous presentation. Unlike traditional comparative
approach, clustering algorithms use empirical statistical
methods to discover subtypes based on intrinsic patterns
within the data without making any a priori assumption
or preconceived notion on how the classification scheme
should be constructed. This unbiased, data driven
approach may provide novel insights and more precise
classification of patient subtypes. To our knowledge,
consensus clustering has not been reported for OAB
patients. In this study, we incorporated patients’ urinary
symptoms and non-urologic factors into consensus clustering to identify potential patient subtypes within OAB.

Materials and methods
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psychological stress (Perceived Stress Scale, PSS) [18], (4)
somatic symptom burden (Poly-Symptomatic, Poly-Syndromic Questionnaire, PSPS-Q) [19], and (5) reported
exposure to various childhood trauma (Childhood Traumatic Events Scale, CTES) [20].
Intensity of bladder pain was assessed using a 0–10
numeric rating scale. Intensity of non-urologic pain was
assessed using the Brief Pain Inventory (BPI) [21]. The
distribution of pain was assessed using a whole body map
as previously described [22]. Those reporting pain in 3
or more broader body regions outside the pelvis (left or
right upper extremity, left or right lower extremity, head
and neck, chest, lower back) were classified as having
“widespread pain” [22].
Condition-specific quality of life was assessed using
the OAB-q QOL subscale (OAB-q-HRQOL) [13]. Global
quality of life was assessed using the SF-36.

OAB participants

Clustering analysis

Male and female patients with OAB seen between October 2012 and July 2014 were approached to participate in
this research study. The case definition of OAB was consistent with the 2002 International Continence Society
terminology [11]. Specifically, OAB patients must have
complaints of urinary urgency, with or without urgency
urinary incontinence, usually with frequency and nocturia, in the absence of other causes. Exclusion criteria included: history of prostate surgery, incontinence
surgery, urethral stricture, neurogenic bladder, urinary
retention, pelvic radiation, cyclophosphamide cystitis,
tuberculosis cystitis, urologic cancer, urinary stones,
positive urine culture in the past 6 weeks, or residual volume ≥ 150 mL. The study was approved by Washington
University Institutional Review Board. All participants
signed an informed consent.

Variables entering k-means consensus clustering
included urinary incontinence (ICIQ-UI), OAB symptoms (ICIQ-OAB), anxiety (HADS), depression (HADS),
psychological stress (PSS), somatic symptom burden
(PSPS-Q), reported exposure to childhood trauma
(CTES), and bladder pain (0–10). K-means uses Euclidean distance to group participants into clusters, while
assigning observations to clusters in order to minimize
the distance between observations and the mean or
center of the cluster, or the total intra-cluster variation
[23, 24]. The optimal number of clusters was estimated
using the elbow method and compared to a number of
different techniques for determining number of clusters using the NbClust package within the R statistical
software to validate the choice [25]. We performed oneway ANOVA and chi-square tests for continuous and
categorical variables respectively to test for differences
between clusters. p < 0.05 was considered significant. All
statistical analyses utilized the open source statistical
package R v3.3.1.

Assessment

Urinary symptoms, psychosocial symptoms, bladder
pain, systemic pain, and quality of life were assessed
using validated questionnaires.
OAB symptoms were assessed using the International
Consultation on Incontinence—Overactive Bladder
(ICIQ-OAB) [12] and OAB-q short form [13]. Urgency
symptoms were assessed using the Indevus Urgency
Severity Scale (IUSS) [14] and on a 0–10 numeric rating
scale of urgency. Urinary incontinence symptoms were
assessed using International Consultation on Incontinence—Urinary Incontinence short form (ICIQ-UI) [15]
and Incontinence Impact Questionnaire Short Form
(IIQ-7) [16].
The following psychosocial symptoms were
assessed: (1) anxiety (Hospital Anxiety and Depression Scale, HADS) [17], (2) depression (HADS) [17], (3)

Comparing the discovered oab clusters to interstitial
cystitis/bladder pain syndrome

Since one of the identified OAB clusters had pain and
psychosocial symptoms (see results below), in order to
verify that our OAB population was distinct from interstitial cystitis/ bladder pain syndrome (IC/BPS), we compared the bladder pain and urinary incontinence scores
of our two identified OAB clusters to an IC/BPS cohort
that was previously described [26]. IC/BPS patients were
required to have an unpleasant sensation (pain, pressure,
discomfort) perceived to be related to the bladder, associated with lower urinary tract symptoms of more than
6 weeks duration, in the absence of infection or other
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identifiable causes, in accordance with the 2011 AUA
Guideline [27]. The distinction between OAB and IC/
BPS was based on the two published AUA Guidelines
[27, 28], chief complaint, and overall clinical impression,
taken into the account of their clinical evaluation and
management (e.g., antimuscarinics for OAB, tricyclics
for IC/BPS). Additionally, we assessed the likely diagnosis
of the OAB patients by applying a previously described
independent nomogram, which has a 94% accuracy for
classifying or distinguishing patients as likely OAB versus
likely IC/BPS based on GUPI, ICSI, and OAB-q [29]. Due
to missing data, the Urge Incontinence Composite Index
was based on only questions four and eight of the OAB-q.

Results
48 OAB patients (13 men, 35 women) had complete data
for consensus clustering. Their characteristics are presented in Table 1. k-means clustering identified two OAB
clusters: a urinary cluster and systemic cluster. The two
clusters are illustrated in selected scatter plots in Fig. 1
(+ = systemic cluster, o = urinary) Comparisons between
the two clusters are shown in Table 1.

Page 3 of 7

There was a near equal percent split between the two
clusters (52% urinary, 48% systemic). There were no age
and sex differences between the two clusters.
The systemic cluster was characterized by significantly higher psychosocial burden of anxiety (HADSA, 9.5 vs. 3.7, p < 0.001), depression (HADS-D, 6.9 vs.
3.6, p < 0.001), psychological stress (PSS, 21.4 vs. 12.9,
p < 0.001), somatic symptom burden (PSPS-Q, 28.0 vs.
7.5, p < 0.001), and reported exposure to traumatic stress
as a child (CTES, 17.0 vs. 5.4, p < 0.001), compared to
the urinary cluster. The systemic cluster also reported
more intense bladder pain (3.3 vs. 0.8 on a 0–10 scale,
p = 0.002), more intense non-urologic pain (BPI, 3.1
vs. 1.7, p = 0.021), and more widespread distribution
of pain (34.8% vs. 4.0%, p = 0.009). The systemic cluster
had worse urinary incontinence (ICIQ-UI, 14.0 vs. 10.7,
p = 0.028), condition-specific quality of life (OAB-qHRQOL, 56.0 vs. 40.3, p = 0.045), and global quality of
life (SF-36, 43.7 vs. 74.6, p < 0.001). The two clusters were
indistinguishable by their urgency symptoms (no differences in ICIQ-OAB, OAB-q, IUSS, and 0–10 urgency ratings, p all > 0.05).

Table 1 Comparisons between the two OAB clusters, mean ± SD
Urinary cluster
(n = 25, 52%)

Systemic cluster
(n = 23, 48%)

p-value

53.8 ± 13.9

54.2 ± 10.0

0.84

19

0.20

10.7 ± 5.1

14.0 ± 4.1

0.028*

8.8 ± 2.7

9.9 ± 2.6

0.20

5.5 ± 4.1

9.5 ± 3.7

< 0.001*

12.9 ± 6.4

21.4 ± 7.0

< 0.001*

17.0 ± 11.6

< 0.001*

Demographics
Age (mean ± SD)
No. of females

Urinary symptoms: (mean ± SD)

Urinary incontinence (ICIQ-UI, 0–21)^
Incontinence impact (IIQ-7, 0–28)
Overactive bladder (ICIQ-OAB, 0–16)^
Overactive bladder symptom severity (OAB-q SS, 6–36)

Psychosocial
Anxiety (HADS-A, 0–21)^
Depression (HADS-D, 0–21)^
Psychological stress (PSS, 0–40)^
Somatic symptom burden (PSPS-Q, 0–59)^
Childhood traumatic exposure (CTES, 0–42)^
Death in family
Parental upheaval
Sexual trauma
Victim of violence
Major illness
Other trauma
Quality of life
Condition specific (OAB-q-HRQOL, 0–100, higher is worse)
Global QOL (SF-36, 0–100, lower is worse)
*p < 0.05. ^ identifies variables that are used in the clustering algorithm

16

6.5 ± 7.4

58.5 ± 20.0

3.7 ± 3.5

7.5 ± 6.6

5.4 ± 6.0

2.1 ± 2.8

0.8 ± 1.8

0.6 ± 1.9

0.6 ± 1.9

0.2 ± 0.8

1.2 ± 2.4
40.3 ± 22.6

74.6 ± 17.8

11.7 ± 8.6

0.027*

69.3 ± 22.4

0.11

6.9 ± 3.6

< 0.001*

28.0 ± 7.6

< 0.001*

3.7 ± 3.2

0.070

3.1 ± 3.2

0.004*

2.4 ± 2.9

0.001*

2.7 ± 3.2

0.021*

2.5 ± 3.2

0.017*

2.6 ± 3.0

0.055

56.0 ± 26.9

43.7 ± 18.4

0.045*
< 0.001*
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Fig. 1 Distribution of urinary and psychosocial measures. o = urinary cluster, +  = systemic cluster

There were strong correlations between anxiety,
depression, and stress across the two clusters (r = 0.78–
0.62, see Table 2). This is illustrated in Fig. 1A, B. Correlations between psychosocial and urinary measures were
weaker (r = 0.42 to 0.09, Fig. 1C). A combination of high
somatic symptom burden and high childhood traumatic
scores (blue dots in top right corner of Fig. 1D) appeared
to separate the systemic cluster from the urinary cluster
which has both low somatic symptom and low childhood
traumatic scores (red dots in the bottom left corner).
We compared the bladder pain and urinary incontinence scores of our two identified OAB clusters to a

known IC/BPS cohort to verify that our OAB population was not an IC/BPS population that was misclassified as patients with OAB. Results showed that the
systemic cluster had significantly less bladder pain
(3.3 vs. 6.6, p < 0.001) and more urinary incontinence
(ICIQ-UI, 14.0 vs. 6.6, p < 0.001) compared to IC/BPS
patients (Table 3). Additionally, we found that 46 of
the 48 patients within our clinically diagnosed OAB
cohort, which includes both the urinary and systemic
cluster patients, were classified as likely OAB using
the nomogram described by Ackerman et al. [29]. The
additional 2 patients had insufficient data to use the
nomogram.
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Table 2 Correlation coefficients between urinary and psychosocial measures
HADS-D
(depression)

HADS-A

PSS

PSPS-Q

CTES

SHCU Q2

ICIQ-UI

ICIQ-OAB (overactive bladder)

0.30

0.37

0.24

0.17

0.11

0.39

0.42

0.40

0.40

0.09

− 0.09

0.43

ICIQ-UI (urinary incontinence)
SHCU Q2 (bladder pain)

0.23

0.18

0.32

0.45

0.39

CTES (childhood traumatic exposure scale)

0.07

0.16

0.20

0.44

0.54

PSPS-Q (somatic symptom burden)

0.38

0.41

PSS (stress)

0.62

0.78

HADS-A (anxiety)

0.77

0.16

Table 3 Comparisons of the two identified clusters to IC/BPS
Urinary cluster
(n = 25)
Age (mean ± SD)

53.8 ± 13.9

No. of females

16

Bladder pain (0–10)

0.8 ± 1.7

Urinary incontinence (ICIQ- 10.7 ± 5.1
UI, 0–21)

Systemic cluster
(n = 23)
54.2 ± 10.0

19

3.3 ± 3.0

14.0 ± 4.1

IC/BPS comparison
group
(n = 27)
44.8 ± 16.6

p-value, urinary OAB
versus IC/BPS

p-value, systemic
OAB versus IC/BPS

0.036*

0.028*

27

< 0.001*

0.038*

6.6 ± 2.1

< 0.001*

< 0.001*

0.012*

< 0.001*

6.6 ± 5.1

*p < 0.05

Discussion
We identified two subtypes of OAB patients using symptom-based consensus clustering: a urinary cluster and a
systemic cluster. The systemic cluster, which consisted
of about half of the cohort, was characterized by significantly higher psychosocial burden of anxiety, depression, psychological stress, somatic symptom burden, and
reported exposure to traumatic stress as a child, compared to the urinary cluster. The systemic cluster also
reported more intense bladder pain, more widespread
distribution of pain, worse urinary incontinence, and
poorer quality of life.
We believe that the systemic cluster was not simply an
IC/BPS population mimicking OAB. Even though the
systemic cluster had higher pain and psychosocial symptoms compared to the urinary cluster, the systemic cluster had significantly less bladder pain and more urinary
incontinence compared to IC/BPS. Furthermore, the
patients in both clusters were classified as OAB using a
previously described independent nomogram, which had
a diagnostic accuracy of 94% in their validation cohort
[29]. These findings make it unlikely that patients in the
systemic cluster had IC/BPS, which further supports this
previously unrecognized cluster as a subtype of OAB.
Many of the differences between the two clusters were
not only statistically different, but likely were clinically
significant. The anxiety, stress, somatic symptom, and
childhood trauma scores in the systemic cluster were

73%, 66%, 270% and 220% higher respectively than those
in the urinary cluster. The systemic cluster had bladder
pain in the mild pain category (mean 3.3 on a 0–10 scale)
vs. minimal pain (mean 0.8) in urinary cluster. The systemic cluster was 7.7 times more likely to report widespread pain.
Even with different questionnaires (ICIQ-OAB, OABq, IUSS, and 0–10 urgency ratings), patients in our two
identified clusters had indistinguishable urgency symptoms. This indicates that those patients belonging to the
group with more systemic difficulties would be hard to
distinguish from their counterparts in a setting where
patients with OAB are only evaluated in regard to their
syndrome defining urinary symptoms. Additional instruments (e.g., HADS and a body map) are needed to distinguish between these two groups in a clinical setting.
The identification of a systemic cluster in OAB is new.
It appears that a subset of OAB patients (the systemic
cluster) may not be “just” an OAB patient with “only”
bladder symptoms. The finding of increased psychosocial burden and non-zero pain in OAB was relatively new
in the literature. In a study comparing OAB and IC/BPS
patients, 33% of OAB patients reported pain or discomfort associated with bladder filling [26]. A subset of OAB
patients also reported urogenital pain and widespread
pain [30]. The presence of pelvic pain was associated with
worse psychosocial health [30]. High anxiety, depression,
psychological stress, and somatic symptom burden were
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also associated with more severe urinary incontinence,
and poorer quality of life [4–7, 10]. Our consensus clustering results have grouped these patients into a distinct
systemic cluster. Notice that there were strong correlations among the various psychosocial measures, suggesting that individuals high in one psychosocial construct
(e.g., anxiety) were more likely to have other psychosocial
measures (e.g., depression, stress, see Fig. 1A, B).
Consideration of non-urologic factors such as psychological and pain profiles might be important in clinical
phenotyping of OAB. Our results highlighted that the
OAB population is heterogeneous and there may be different subtypes of OAB (a systemic cluster vs. urinary
cluster). It is unclear whether the two identified clusters
might have different underlying pathophysiology. Conceptually it is possible that the systemic cluster might
have “top-down” or systemic mechanisms such as central sensitization, systemic inflammation, or psychosocial
trauma. Central sensitization has recently been demonstrated in some OAB patients by Reynolds et al. [8, 9]. In
future studies it is important to study the differences in
pathophysiology among the OAB subtypes.
At this time, it is unclear what the therapeutic implications are in terms of treatments. We do not know
whether there will be differential responses to OAB treatments between the two identified clusters. We hypothesize that the systemic cluster might be less responsive
to traditional OAB treatments while those in the urinary
cluster might respond more favorably. Theoretically one
might consider the systemic cluster to be out of boundary
of bladder-centric treatments and therefore might be less
responsive or non-responsive to traditional treatments of
OAB that focus on the bladder (e.g., oral antimuscarinics,
beta-agonist, botox injection, pelvic floor therapy). This
systemic cluster may explain why some OAB patients
were “refractory” to traditional treatments of OAB. It
may also explain why OAB as a whole can be difficult to
treat effectively because it is a heterogeneous condition
with many subtypes that are poorly understood.
Reynolds et al. have shown that patients requiring third
line treatment for OAB (“refractory” patients) demonstrated higher rates of central sensitization when compared to patients who were first presenting for OAB
treatment (treatment naïve) [9]. This observation lends
credence to our hypothesis. It also supports the validity
of this systemic cluster as a subgroup of patients within
OAB that can be identified using clinical measures and
potentially treated more effectively with different therapies than their counterparts in the urinary cluster. A
larger cohort with longer term treatment data is necessary to investigate this hypothesis.
Further research is needed to validate the two identified OAB clusters, and to further assess whether or not
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the clusters identified here would respond differentially
to OAB treatments. At this time we are not ready to
advocate the use of additional questionnaires in clinical practice to assess non-urologic features in OAB
patients. We need more research to assess the additional value of evaluating OAB patients with respect to
their systemic profiles.
The limitations of this study are inherent to the use
of clustering algorithms and the subjective nature
of patient reported symptoms. The characteristics
included in the model will impact how the patients can
be grouped optimally. While these limitations exist,
previous work supports the presence of an OAB subtype that fits the characteristics of our systemic cluster
and suggests the potential for improvement in treatment algorithms if these subtypes could be identified
in clinical practice. Another limitation is the small
sample size. Future work should focus on establishing
the reproducibility of these clusters in a larger data set,
establishing the thresholds for membership between
these clusters, assessing if there are treatment response
differences between them, and examining their differences in pathophysiology. Moving clinical phenotyping research beyond symptom-based classification by
incorporating other mechanistic data (e.g., biomarkers,
functional MRI) in the future is also important.

Conclusions
The OAB population is heterogeneous and symptombased clustering has identified two clusters of OAB
patients (a systemic cluster vs. a urinary cluster).
Understanding the pathophysiology of OAB subtypes
may facilitate treatments.
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